ȨÀ¸·Î ȸ¿ø°ø°£ - °øÁö»çÇ×
2016³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ÇÏ°è¿öÅ©¼¥ ¾È³»
» ÀÛ¼ºÀÚ : °ü¸®ÀÚ » ÀÛ¼ºÀÏ : 2016-06-20 » Á¶È¸ : 1384
» ÷ºÎÆÄÀÏ : ÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
2016³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ÇÏ°è¿öÅ©¼¥ ¾È³»

Ȳ»ç°¡ ±â½ÂÀ» ºÎ¸®°í ÀÖÀ¸³ª º½ ±â¿îÀÌ ¿Ï¿¬ÇÑ ÁîÀ½ ȸ¿ø ¿©·¯ºÐ ¾È³çÇϽʴϱî?
ȸ¿ø´ÔÀÇ °Ç½ÂÀ» ±â¿øÇÕ´Ï´Ù.
2016³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ÇÏ°è¿öÅ©¼¥¿¡ ´ëÇÑ ¾È³»¸¦ ÇÏ°íÀÚ ÇÕ´Ï´Ù.

•  Àå¼Ò: õ¾È»ó·Ï¸®Á¶Æ®
•  ÀϽÃ: 2016³â 7¿ù 9ÀÏ(Åä) ~ 10ÀÏ(ÀÏ)
•  ÇÁ·Î±×·¥: ÃßÈÄ °øÁö
•  Ãß°¡Á¢¼ö ½Åû ¸¶°¨ : Á¢¼ö½Åû ¸¶°¨
•  Á¢¼ö ¹æ¹ý : ÇÏ´Ü ½Åû¼­ ´Ù¿î·Îµå ÈÄ ½Åû¼­ ÀÛ¼º »ç¹«±¹ ¸ÞÀÏ Á¢¼ö
⇒ ½Åû¼­ »ç¹«±¹ ¸ÞÀÏÁ¢¼ö : gaonpco@gaonpco.com or gaonpco@naver.com
•  ÁÖ¿ä ¿¬¶ôó
⇒ Ãѹ«ÀÌ»ç ¹ÚÈñÆò : E-mail : hppark@snu.ac.kr / M : 010-2971-7647
⇒ ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ »ç¹«±¹(°¡¿ÂÄÁº¥¼Ç) Çѹμö °úÀå :
⇒ E-mail : gaonpco@gaonpco.com or gaonpco@naver.com
    Tel : 031-987-5963 / M : 010-5317-2735



* ÇÁ·Î±×·¥
½Ã°£ÇÁ·Î±×·¥¿¬ÀÚ
13:30 - 14:00 µî·Ï ¡¡
14:00 - 14:10 ȸÀå´Ô Àλ縻 ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ȸÀå ÀÓ¿µÁø
14:10 - 15:10 ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ¿¬±¸ºñ °úÁ¦ ¹ßÇ¥
1 2014³âµµ ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ ¼±Á¤ÀÚ °á°ú º¸°í
Ç÷¾×-³úÀ庮 º¸ÀüÇÏ´Â Anesthetic Post-ConditioningÀÌ t-PA·Î ÀÎÇÑ ³ú¼Õ»ó¿¡ ¹ÌÄ¡´Â ¿µÇâ
±èÀºÁ¤, ±¸º»³à (¿¬¼¼ÀÇ´ë)
2 2015³âµµ ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ ¼±Á¤ÀÚ °á°ú º¸°í
Glial cell¿¡¼­ ulinastatin¿¡ ÀÇÇÑ glutamate uptakeÀÇ Áõ°¡ È¿°ú
ÀÌÀÏ¿Á (°í·ÁÀÇ´ë)
3 2016³âµµ ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ ¼±Á¤ÀÚ ¿¬±¸°èȹ¼­ ¹ßÇ¥
µ¦½º¸Þµ¥Åä¹ÌµòÀÌ ³úÁöÁÖ¸·ÇÏÃâÇ÷ ÈÄ ¹ß»ýÇÏ´Â ³úÇ÷°ü¿¬Ãà¿¡ ¹ÌÄ¡´Â È¿°ú ¹× »ýü Ç¥ÁöÀÚ ºÐ¼®
¼Û¿µ (¿¬¼¼ÀÇ´ë)
15:10 - 15:40 Ư°­ ÁÂÀå : ±èÇØ±Ô (ºÎ»êÀÇ´ë)
Lipid emulsion as non-specific antidote ¼ÕÁÖÅ (°æ»óÀÇ´ë)
15:40 - 16:00 Coffee Break
16:00 - 17:30 ÀÚÀ¯¿¬Á¦ ¹ßÇ¥
1 A randomized cross-over study comparing cervical spine motion during intubation between two lightwand intubation techniques in patients with simulated cervical immobilization: Laryngoscope-assisted vs. conventional lightwand intubation ¹ÚÈñÆò (¼­¿ïÀÇ´ë)
2 Pretreatment of isoflurane prevents tPA -induced endothelial cell damage and neuronal death by inhibiting MMP activation after hypoxic injury Àü¼Ò¿µ (¿¬¼¼ÀÇ´ë)
3 Blockade of Apoptosis signal-regulating kinase 1 attenuates MMP-9 activity in brain endothelial cells and subsequent apoptosis in neurons after ischemic injury Àü¼Ò¿µ (¿¬¼¼ÀÇ´ë)
4 Population pharmacodynamic modeling of the sedative effects of propofol in pediatric patients undergoing brain MRI Çѵ¿¿ì (¿¬¼¼ÀÇ´ë)
18:00 Àú³á½Ä»ç


  • Æ¯º°È¸¿ø»ç´Â ÇмúÈ°µ¿ ÇÁ·Î±×·¥¿¡ ¹Ýµå½Ã Âü¼® ÇÒ ÇÊ¿ä´Â ¾ø½À´Ï´Ù. 


  • Ãß°¡ °øÁö »çÇ× •

  * ¼­¿ï Ãâ¹ß ¹ö½º ¾È³»

  - ¼­¿ï < = > õ¾È»ó·Ï¸®Á¶Æ® ¸®¹«Áø ¹ö½º ±³ÅëÆíÀº ¾Æ·¡¿Í °°½À´Ï´Ù.

    ---------- ¾Æ·¡ ----------

  < ¼­¿ï Ãâ¹ß => õ¾È»ó·Ï¸®Á¶Æ® µµÂø >

l  ½Ã°£: 7¿ù 9ÀÏ(Åä) ¿ÀÀü 11½Ã

l  Àå¼Ò: »ç´ç¿ª 1¹øÃⱸ °ø¿µÁÖÂ÷Àå

  < õ¾È Ãâ¹ß => ¼­¿ïµµÂø >

l  ½Ã°£: 7¿ù 10ÀÏ(ÀÏ) Á¡½É½Ä»ç ÈÄ

l  µµÂøÀå¼Ò: ¼­¿ï °­³² (¹ÌÁ¤)

  * Á¡½É½Ä»ç´Â ÇÐȸ¿¡¼­ µû·Î Áö¿øÇÏÁö ¾Ê½À´Ï´Ù.

  * ÇÐȸ¿¡¼­ õ¾È KTX¿ª¿¡¼­ »ó·Ï¸®Á¶Æ®·Î ¿îÇàÇÏ´Â ±³ÅëÆíÀº ¾øÀ¸¸ç,  
   
ºÎµæÀÌÇÏ°Ô KTX¸¦ ÀÌ¿ëÇϽô ºÐµéÀº ºÒÆíÇϽôõ¶óµµ °³º° À̵¿ÇØ 
    Áֽñ⸦ ºÎŹµå¸³´Ï´Ù.

    ¶ÇÇÑ ¿öÅ©¼¥ ´çÀÏ Åä¿äÀÏ Àú³á ¼÷¹Ú¾øÀÌ ±Í°¡ÇϽô ȸ¿ø´Ôµé°ú
    ÀÏ¿äÀÏ Á¡½É½Ä»ç¿¡ Âü¼®ÇÏÁö ¾Ê°í
±Í°¡ÇϽô ȸ¿ø´Ôµé²²µµ
    °ø½ÄÀûÀÎ Â÷·®Áö¿øÀº ¾øÀ½À» ¾Ë·Áµå¸³´Ï´Ù



  * ü·Â´Ü·Ã ÇÁ·Î±×·¥ ÁøÇà ¾È³»

   - ÀÏÀÚ : 7¿ù 10ÀÏ(ÀÏ) ¾Æħ 6½Ã ~ 7½Ã »çÀÌ ÁøÇà

   - Àå¼Ò : õ¾È»ó·Ï CC

   - ±âŸ : ÆÀ ¿î¿µÀº Ãß ÈÄ Å뺸, [Á¡½É½Ä»ç´Â ÇÏ´Ü¿¡ º°µµ ±âÁ¦]

 

  * ¼÷¹Ú ÁøÇà °ü·Ã

   - Àå¼Ò : õ¾È»ó·Ï¸®Á¶Æ®È£ÅÚ

   - ºñ¿ë : º°µµ ºñ¿ë ¾øÀ½

   - ±âŸ : °¡Á· µ¿¹Ý ½Ã Ãß°¡ ¿ä±Ý¾øÀÌ 1½Ç Á¦°ø

   - Ã¼Å©ÀÎ : È£ÅÚ Ã¼Å©ÀÎÀº ¿ÀÈÄ 3½ÃºÎÅÍ °¡´É ÇÕ´Ï´Ù. 

   - ¹æ¹èÁ¤ : ¹æ¹èÁ¤Àº üũÀÎ ½Ã È®ÀÎÀÌ °¡´É ÇÕ´Ï´Ù.

 

  * µ¶¸³±â³ä°ü ÁøÇà °ü·Ã

   - ÀϽà : 7¿ù 10ÀÏ(ÀÏ) ¾Æħ ½Ä»ç ÈÄ ¼÷¼Ò ¾Õ¿¡¼­ ¹ö½º·Î Ãâ¹ß

   - ±âŸ : 12½Ã µ¶¸³±â³ä°ü¿¡¼­ Á¡½É½Ä»ç Àå¼Ò·Î Ãâ¹ß ÀÏÁ¤

 

  * Á¡½É½Ä»ç ÁøÇà °ü·Ã

   - Àå¼Ò : º´ÃµÀüÅë¼ø´ë

   - °¡´Â¹æ¹ý

> µ¶¸³±â³ä°üÆÀ : ¹ö½º·Î ´Üü À̵¿

> ¿îµ¿ÆÀ : º´ÃµÀüÅë¼ø´ë·Î °³º°À̵¿

 

  * ±âŸ Á¤º¸

   - õ¾È¾Æ»ê¿ª ¹ö½º Ãâ¹ß ½Ã°£ : ¿ÀÈÄ 12½Ã 40ºÐ Ãâ¹ß ¿¹Á¤



ÇÏ´Ü¿¡ ½Åû¼­ ´Ù¿î·Îµå ÈÄ ½Åû¼­ÀÇ °¢ Ç׸ñÀ» ±âÀÔÇϼż­ ÷ºÎÇÏ¿© ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ »ç¹«±¹
[°¡¿ÂÄÁº¥¼Ç] Çѹμö °úÀå¿¡°Ô ¸ÞÀÏ·Î 6¿ù 13ÀÏ(¿ù) ¿ÀÀü 11½Ã±îÁö º¸³»ÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù.
* Âü¼® ºÒ°¡ÀÎ °æ¿ìµµ ȸ½ÅÀ» ÇØ ÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù. * [Á¢¼ö½Åû ¸¶°¨]

õ¾È»ó·Ï¸®Á¶Æ®
½Åû¼­ ´Ù¿î·Îµå
¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Ã·ºÎ Á¶È¸
56 ´ëÇѳú½Å°æ¸¶Ãë ¿¬±¸Àå·Á±Ý Áö¿ø¾È³» (2017 ASNACC) ÇÐȸ°ü... 2017-05-08 1048
55 2017³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ °úÁ¦ ¼±Á¤ °ø°í ÇÐȸ°ü... 2017-03-14 839
54 2017³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ãá°èÇмú´ëȸ ¾È³» °ü¸®ÀÚ 2017-02-22 1553
53 ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ¿ìâÇмú»ó ¾È³» °ü¸®ÀÚ 2017-02-15 798
52 2017³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ Áö¿ø»ç¾÷ ¾È³» °ü¸®ÀÚ 2016-12-26 783
2016³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ÇÏ°è¿öÅ©¼¥ ¾È³» °ü¸®ÀÚ 2016-06-20 1384
50 2016³â Ưº°¿¬±¸ºñ°¡ ¼±Á¤µÇ¾úÀ½À» °øÁöÇÕ´Ï´Ù. ÇÐȸ°ü... 2016-03-08 1301
49 ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ ¿ìâÇмú»ó ¾È³» ÇÐȸ°ü... 2016-02-04 1285
48 2016³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ Áö¿ø»ç¾÷ ÇÐȸ°ü... 2016-01-05 1282
47 2015³â ´ëÇѳú½Å°æ¸¶ÃëÇÐȸ Ưº°¿¬±¸ºñ °úÁ¦ ¼±Á¤ °ø°í °ü¸®ÀÚ 2015-02-24 1265
   1  ·  2  ·  3  ·  4  ·  5  ·  6  ·  7  ·  8  ·  9  ·  10